Hahn, R G <br/><br/>
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.  [electronic resource] 

 -  Cancer treatment reports  Jul 1978 
 - 1093-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Clinical Trials as Topic<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Medroxyprogesterone--administration & dosage<br/>Neoplasm Metastasis<br/>Nitrosourea Compounds--administration & dosage<br/>Prognosis<br/>Semustine--administration & dosage<br/>Vinblastine--administration & dosage